Historique
Bulletin de Périodique
Addiction , Vol.119, n°10 - October 2024
Paru le :
01/10/2024
Article en page(s) :
1671-1855
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Trends in substance use and related harms among older adults in high-income countries [Editorial]. Sutherland R., Gisev N., Larney S., p. 1676-1678.
- Expanding and adapting prevention and treatment options for older adults who engage in harmful use of substances [Editorial]. Kuerbis A., p. 1679-1681.
- Will Australia's tightened prescription system reduce nicotine vaping among young people? [Addiction opinion and debate]. Hall W.D., p. 1682-1688.
- Addictive and harmful vapes must never be sold as a consumer good. Freeman B., Watts C., p. 1689-1690.
- The ends do not justify the means when it comes to Australia's vaping policy. Cox S., p. 1691-1692.
- Will Australia's tightened prescription system reduce nicotine vaping among young people? Gravely S., Fong G.T., p. 1693-1695.
- Towards more practicable e-cigarette regulation in Australia. Hall W., p. 1696-1697.
- Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map. Conde M., Tudor K., Begh R., Nolan R., Zhu S., Kale D., et al., p. 1698-1708.
- Commentary on Conde et al.: Evidence and gap map offer an important opportunity for dialogue and refinement of the gateway hypothesis controversy. Selya A., Gitchell J.G., p. 1709-1710.
- Commentary on Conde et al.: Addressing evidence gaps on the impact of vaping among young people. East K., p. 1711-1712.
- Systematic review and meta-analyses of cytisine to support tobacco cessation. Puljevic C., Stjepanovic D., Meciar I., Kang H., Chan G., Morphett K., et al., p. 1713-1725.
- Expanding our understanding of long-term trends in alcohol abstention and consumption in England (2001-19) using two age-period-cohort approaches. Opazo Breton M., Henney M., Kersbergen I., Brennan A., Holmes J., p. 1726-1736.
- The association of smoking with different eating and dietary behaviours: A cross-sectional analysis of 80?296 United Kingdom adults. Alruwaili A., King J.A., Deighton K., Kelly B.M., Liao Z., Innes A., et al., p. 1737-1750.
- Prospective longitudinal relations among frequent social media use, nicotine vaping and experiencing internalizing mental health problems. Lee S., Elam K., Lohrmann D., Luo J., Chow A., Seo D.C., p. 1751-1761.
- Effectiveness of residential versus outpatient therapy for smoking cessation: The START randomized clinical trial. Dickreuter J.L., Schmoor C., Jähne A., Bengel J., Pschichholz B., Lorz C., et al., p. 1762-1773.
- Young adult retail purchases of cannabis, product category preferences and sales trends in California 2018-21: Differences compared with older adults. Pechmann C., Calder D., Timberlake D., Rhee J., Padon A., Silver L., p. 1774-1783.
- Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada. Nazif-Munoz J.I., Martinez P., Huynh C., Massamba V., Zefania I., Rochette L., et al., p. 1784-1791.
- Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning. Nateghi Haredasht F., Fouladvand S., Tate S., Chan M.M., Yeow J.J.L., Griffiths K., et al., p. 1792-1802.
- Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder. Mojtabai R., Susukida R., Farokhnia M., Nguyen T.Q., Dunn K.E., Amin-Esmaeili M., p. 1803-1812.
- Predictors of alcohol and other drug treatment completion among young people accessing residential and community-based treatment: A retrospective analysis of routinely collected service data. Wells M., Kelly P.J., Mullaney L., Lee M.L., Stirling R., Etter S., et al., p. 1813-1825.
- The relationship between gambling behaviour and gambling-related harm: A data fusion approach using open banking data. Zendle D., Newall P., p. 1826-1835.
- Commentary on Zendle and Newall: The need for direct evaluation of the UK's gambling affordability checks policy. Heirene R.M., p. 1836-1837.
- Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene. Zendle D., Newall P., p. 1838-1839.
- Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Li M.J., Chau B., Belin T., Carmody T., Jha M.K., Marino E.N., et al., p. 1840-1845.
- Trends in substance use and related harms among older adults in high-income countries [Editorial]. Sutherland R., Gisev N., Larney S., p. 1676-1678.
- Expanding and adapting prevention and treatment options for older adults who engage in harmful use of substances [Editorial]. Kuerbis A., p. 1679-1681.
- Will Australia's tightened prescription system reduce nicotine vaping among young people? [Addiction opinion and debate]. Hall W.D., p. 1682-1688.
- Addictive and harmful vapes must never be sold as a consumer good. Freeman B., Watts C., p. 1689-1690.
- The ends do not justify the means when it comes to Australia's vaping policy. Cox S., p. 1691-1692.
- Will Australia's tightened prescription system reduce nicotine vaping among young people? Gravely S., Fong G.T., p. 1693-1695.
- Towards more practicable e-cigarette regulation in Australia. Hall W., p. 1696-1697.
- Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map. Conde M., Tudor K., Begh R., Nolan R., Zhu S., Kale D., et al., p. 1698-1708.
- Commentary on Conde et al.: Evidence and gap map offer an important opportunity for dialogue and refinement of the gateway hypothesis controversy. Selya A., Gitchell J.G., p. 1709-1710.
- Commentary on Conde et al.: Addressing evidence gaps on the impact of vaping among young people. East K., p. 1711-1712.
- Systematic review and meta-analyses of cytisine to support tobacco cessation. Puljevic C., Stjepanovic D., Meciar I., Kang H., Chan G., Morphett K., et al., p. 1713-1725.
- Expanding our understanding of long-term trends in alcohol abstention and consumption in England (2001-19) using two age-period-cohort approaches. Opazo Breton M., Henney M., Kersbergen I., Brennan A., Holmes J., p. 1726-1736.
- The association of smoking with different eating and dietary behaviours: A cross-sectional analysis of 80?296 United Kingdom adults. Alruwaili A., King J.A., Deighton K., Kelly B.M., Liao Z., Innes A., et al., p. 1737-1750.
- Prospective longitudinal relations among frequent social media use, nicotine vaping and experiencing internalizing mental health problems. Lee S., Elam K., Lohrmann D., Luo J., Chow A., Seo D.C., p. 1751-1761.
- Effectiveness of residential versus outpatient therapy for smoking cessation: The START randomized clinical trial. Dickreuter J.L., Schmoor C., Jähne A., Bengel J., Pschichholz B., Lorz C., et al., p. 1762-1773.
- Young adult retail purchases of cannabis, product category preferences and sales trends in California 2018-21: Differences compared with older adults. Pechmann C., Calder D., Timberlake D., Rhee J., Padon A., Silver L., p. 1774-1783.
- Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada. Nazif-Munoz J.I., Martinez P., Huynh C., Massamba V., Zefania I., Rochette L., et al., p. 1784-1791.
- Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning. Nateghi Haredasht F., Fouladvand S., Tate S., Chan M.M., Yeow J.J.L., Griffiths K., et al., p. 1792-1802.
- Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder. Mojtabai R., Susukida R., Farokhnia M., Nguyen T.Q., Dunn K.E., Amin-Esmaeili M., p. 1803-1812.
- Predictors of alcohol and other drug treatment completion among young people accessing residential and community-based treatment: A retrospective analysis of routinely collected service data. Wells M., Kelly P.J., Mullaney L., Lee M.L., Stirling R., Etter S., et al., p. 1813-1825.
- The relationship between gambling behaviour and gambling-related harm: A data fusion approach using open banking data. Zendle D., Newall P., p. 1826-1835.
- Commentary on Zendle and Newall: The need for direct evaluation of the UK's gambling affordability checks policy. Heirene R.M., p. 1836-1837.
- Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene. Zendle D., Newall P., p. 1838-1839.
- Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Li M.J., Chau B., Belin T., Carmody T., Jha M.K., Marino E.N., et al., p. 1840-1845.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
R. SUTHERLAND ;
N. GISEV ;
S. LARNEY
|
2024
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
It was hypothesised more than 20 years ago that as the baby boomer generation aged, there would be an increase in substance use and related harms among older adults. There is an increasing body of evidence to support these projections, however, [...]
Nouveauté
Public health education and adapting formal treatments are critical for optimal success with older adults who engage in harmful use of substances. Varied modalities, formats, topics and settings are required for maximum impact. [Author's abstract]
Nouveauté
M. CONDE ;
K. TUDOR ;
R. BEGH ;
R. NOLAN ;
S. ZHU ;
D. KALE ;
S. JACKSON ;
J. LIVINGSTONE-BANKS ;
N. LINDSON ;
C. NOTLEY ;
J. HASTINGS ;
S. COX ;
M. F. PESKO ;
J. THOMAS ;
J. HARTMANN-BOYCE
|
2024
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
BACKGROUND AND AIMS: The use of e-cigarettes may influence later smoking uptake in young people. Evidence and gap maps (EGMs) are interactive on-line tools that display the evidence and gaps in a specific area of policy or research. The aim of t[...]
Nouveauté
C. PULJEVIC ;
D. STJEPANOVIC ;
I. MECIAR ;
H. KANG ;
G. CHAN ;
K. MORPHETT ;
H. BENDOTTI ;
G. KUNWAR ;
C. GARTNER
|
2024
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique
BACKGROUND AND AIMS: Cytisine (also known as cytisinicline) is a low-cost partial agonist of nicotinic acetylcholine receptors used to assist tobacco cessation. We aimed to review the effectiveness of cytisine for tobacco cessation and the effec[...]